OSCE stationDrNB Cardiology – Viva master list

Nuclear cardiology OSCE: 40 stations

40 stationsLast reviewed: October 2026
Merit MedScript seal

Nuclear cardiology separates candidates who understand physiology from those who memorise images: examiners test whether you can tell a true perfusion defect from an artifact. Each station gives the analysis, the morphology, the clinical goal, an identification tip and a consultant note.

How to present in the viva: Before calling “ischaemia” or “infarct”, state three things: the radiotracer (e.g., Tc-99m sestamibi for perfusion, F-18 FDG for metabolism and viability, Tc-99m PYP for amyloid), the stress modality (exercise or pharmacological — adenosine, regadenoson or dobutamine) and the planes shown (short axis, vertical long axis, horizontal long axis). This shows you understand the protocol and secures the baseline marks.

AMyocardial perfusion imaging (SPECT): pathology

1.Normal Myocardial Perfusion Imaging

  • Analysis: Perfusion scan showing uniform and symmetrical radiotracer uptake throughout the entire left ventricular myocardium during both stress and rest phases.
  • Morphology: Complete, homogeneous tracer distribution is maintained across all three standard orthogonal planes, which are the Short Axis, Vertical Long Axis, and Horizontal Long Axis.
  • Clinical goal: Conclude a normal study to rule out obstructive epicardial coronary artery disease and document an excellent long-term prognosis.
  • Identification tip: The left ventricle appears as a bright, perfectly solid donut on short axis views and a symmetrical horseshoe on long axis views without any dark zones.
  • Consultant note: A normal perfusion scan has a high negative predictive value: the annual risk of cardiac death or MI is under 1%.

2.Reversible Ischemia in LAD territory

  • Analysis: Perfusion scan demonstrating a distinct, inducible perfusion defect matching the anterior wall and interventricular septum.
  • Morphology: Stress images show a severe, dark reduction in radiotracer uptake, which completely fills in and normalizes to a bright signal on the corresponding rest images.
  • Clinical goal: Identify significant, flow-limiting stenosis within the Left Anterior Descending coronary artery to guide targeted revascularization.
  • Identification tip: Look for a dark segment on the top and left side of the stress donut that completely disappears on the rest donut.
  • Consultant note: Finding a large zone of inducible anterior ischemia represents a high-risk scan that strongly dictates coronary angiography and percutaneous intervention.

3.Reversible Ischemia in RCA territory

  • Analysis: Perfusion scan evaluating blood flow across the inferior diaphragmatic myocardial segments.
  • Morphology: A localized, dark zone of reduced tracer uptake is visible strictly in the inferior wall and basal septum during stress, reverting to normal uptake at rest.
  • Clinical goal: Confirm a hemodynamically significant lesion within the Right Coronary Artery in a right-dominant system.
  • Identification tip: The bottom segment of the short-axis donut is completely dark on the stress row but matches the bright intensity of the other segments on the rest row.
  • Consultant note: Always evaluate raw projection images to ensure a suspected inferior defect is not a false artifact caused by diaphragmatic attenuation.

4.Reversible Ischemia in LCx territory

  • Analysis: Perfusion scan assessing the lateral free wall of the left ventricle.
  • Morphology: Stress images demonstrate a clear, inducible reduction in radiotracer intensity restricted entirely to the lateral and inferolateral segments, resolving at rest.
  • Clinical goal: Identify flow-limiting lesions within the Left Circumflex coronary artery or its major obtuse marginal branches.
  • Identification tip: The right side of the short-axis donut (corresponding to the anatomical left lateral wall) turns dark under stress and brightens at rest.
  • Consultant note: Isolated lateral ischaemia is easily missed or underestimated; check the horizontal long-axis slices for confirmation.

5.Fixed Defect

  • Analysis: Perfusion scan documenting permanent myocardial scar tissue from a prior myocardial infarction.
  • Morphology: Demonstrates an absent or severely reduced radiotracer signal in a specific coronary territory that remains completely unchanged between the stress and rest phases.
  • Clinical goal: Confirm the presence, location, and precise size of an old myocardial infarction to assess regional tissue viability.
  • Identification tip: The affected wall remains completely dark and cold across both rows of images, never showing any improvement or tracer filling.
  • Consultant note: A fixed defect usually means scar, but severely hibernating myocardium can look the same — assess viability with FDG PET or thallium if revascularisation is being considered.

6.Mixed Defect

  • Analysis: Perfusion scan demonstrating inducible ischemia superimposed directly on an area of chronic myocardial scar.
  • Morphology: A baseline fixed defect is present at rest, but under stress, the dark zone either significantly deepens in severity or expands outward into adjacent segments.
  • Clinical goal: Identify residual, at-risk viable myocardium bordering an old infarct zone that would benefit from targeted revascularization.
  • Identification tip: The dark area on the rest donut gets visibly larger or darker on the stress donut, pointing to peri-infarct ischemia.
  • Consultant note: Revascularizing a mixed defect helps preserve the remaining viable borders, preventing adverse left ventricular remodeling and worsening heart failure.

7.Transient Ischemic Dilation

  • Analysis: A high-risk, non-perfusion marker calculated by dividing the stress left ventricular cavity volume by the rest cavity volume.
  • Morphology: The left ventricular cavity appears visually much larger and dilated on the stress images compared to the compact rest images.
  • Clinical goal: Identify balanced, multi-vessel CAD or critical Left Main disease that causes diffuse, global subendocardial ischemia.
  • Identification tip: The internal dark center of the stress donut looks significantly wider than the rest donut, despite the epicardial borders remaining stable.
  • Consultant note: TID is a high-risk sign; it usually reflects severe, diffuse subendocardial ischaemia that makes the cavity look larger on stress images (a TID ratio above about 1.2, depending on protocol).

8.Increased lung uptake on stress

  • Analysis: Raw and processed perfusion images evaluating extracardiac radiotracer distribution during the stress phase.
  • Morphology: Displays a high, abnormal concentration of the radiotracer within the lung fields on stress images, which normalizes completely on rest images.
  • Clinical goal: Identify stress-induced severe left ventricular dysfunction and a dangerous elevation in left ventricular end-diastolic pressure.
  • Identification tip: The heart silhouette is obscured or surrounded by a hazy, bright cloud in the lungs on the stress scan, whereas the rest scan background is clean.
  • Consultant note: A lung-to-heart ratio above 0.5 with thallium-201 (above about 0.44 with Tc-99m sestamibi) indicates stress-induced LV dysfunction with raised filling pressure and is a high-risk marker of multivessel or left main disease.

9.Increased Right Ventricular Uptake

  • Analysis: Perfusion scan evaluating the visual relationship between right and left ventricular radiotracer intensity.
  • Morphology: The thin right ventricular wall becomes intensely visible on rest images, displaying a signal intensity that approaches or exceeds the left ventricular signal.
  • Clinical goal: Identify severe right ventricular hypertrophy or advanced pulmonary hypertension.
  • Identification tip: A prominent, bright crescent shape appears tracking the right side of the left ventricular donut on all short-axis slices.
  • Consultant note: The normal RV wall is barely visible because of its low mass; clearly visible RV uptake at rest suggests RV hypertrophy from pressure overload.

BSPECT artifacts

10.Breast Attenuation Artifact

  • Analysis: Perfusion scan demonstrating an apparent defect in a female patient, typically localized to the anterior or anterolateral segments.
  • Morphology: Appears as a fixed or occasionally partially reversible reduction in radiotracer uptake that mimics an LAD territory lesion.
  • Clinical goal: Correctly identify soft-tissue attenuation to prevent unnecessary and invasive coronary angiography.
  • Identification tip: The tie-breaker is checking the gated SPECT images; if regional wall motion and systolic wall thickening are perfectly normal, it confirms an artifact rather than an infarct.
  • Consultant note: Prone imaging, attenuation correction or a breast binder shifts or corrects for the breast tissue and confirms that the defect resolves.

11.Diaphragmatic Attenuation Artifact

  • Analysis: Perfusion scan showing a false abnormality along the diaphragmatic surface of the heart, most prevalent in male or obese patients.
  • Morphology: A fixed, dark reduction in radiotracer intensity localized strictly to the inferior myocardial wall across the short-axis slices.
  • Clinical goal: Differentiate true RCA scar tissue from simple photon absorption by the underlying left hemidiaphragm.
  • Identification tip: Look at the gated SPECT frames; preserved inferior wall motion and robust systolic thickening confidently rule out a true myocardial infarction.
  • Consultant note: Prone imaging alongside supine acquisition, or CT/attenuation-corrected imaging, is the standard way to confirm this common artifact.

12.Patient motion artifact

  • Analysis: Severe reconstruction error caused by the patient shifting their position vertically or horizontally midway through a SPECT acquisition.
  • Morphology: Displays a highly characteristic hurricane sign, showing a distorted, smeared, or sharply misaligned layout of the myocardial walls.
  • Clinical goal: Identify data degradation early to mandate an immediate repeat scan instead of attempting to interpret an un-interpretable study.
  • Identification tip: The definitive proof requires evaluating the raw, rotating projection data; a step-discontinuity or vertical break in the sinogram or linogram confirms motion.
  • Consultant note: Even minor patient movement of just one to two pixels can create false-positive reversible defects that completely mimic coronary ischemia.

13.Apical Thinning Artifact

  • Analysis: An apparent reduction in radiotracer intensity restricted entirely to the apex of the left ventricle.
  • Morphology: Appears as a focal, dark spot or partial thinning at the tip of the horseshoe shape on vertical and horizontal long-axis views.
  • Clinical goal: Correctly recognize a normal anatomical variant and partial volume effect to prevent misdiagnosing an apical infarct.
  • Identification tip: The focal reduction is accompanied by normal apical inward movement and preserved wall thickening during the systolic phase of gated imaging.
  • Consultant note: The myocardial wall is naturally thinnest at the apex, making it vulnerable to partial-volume effect on lower-resolution SPECT cameras; attenuation correction can accentuate it.

14.LBBB septal artifact

  • Analysis: A notorious false-positive perfusion defect tracking the interventricular septum, induced specifically by exercise or dobutamine stress.
  • Morphology: Displays a false, highly convincing reversible septal defect that mimics critical proximal LAD stenosis.
  • Clinical goal: Understand the mechanism (asynchronous septal contraction at high heart rates) and avoid exercise or dobutamine stress in patients with left bundle branch block.
  • Identification tip: The defect appears during high-heart-rate exercise due to abbreviated diastole and reduced septal blood flow, completely resolving at rest.
  • Consultant note: This specific subset of patients strictly mandates pharmacological vasodilator stress using adenosine or regadenoson to achieve uniform, non-rate-dependent hyperemic flow.

15.Upward Creep Artifact

  • Analysis: A false perfusion defect driven by a gradual, physiological upward migration of the heart within the thoracic cavity during a post-exercise scan.
  • Morphology: Characteristically creates a false-positive reversible inferior wall defect, mimicking an active RCA lesion.
  • Clinical goal: Identify the mechanical effect of resolving heavy exercise diaphragmatic excursion to adjust scan timing protocols.
  • Identification tip: Occurs mainly when acquisition starts too soon after strenuous treadmill exercise, while the patient is still breathing deeply and the diaphragm gradually returns to its resting position.
  • Consultant note: Waiting about 15 minutes after exercise before acquisition lets breathing and diaphragm position settle and largely prevents upward creep.

16.Splanchnic Overlap

  • Analysis: Intense, avid radiotracer accumulation within close-proximity abdominal organs that interferes with subdiaphragmatic cardiac imaging.
  • Morphology: Massive, brilliant hyper-accumulation within the liver, gallbladder, or loops of bowel that physically touches or overlaps the inferior border of the heart.
  • Clinical goal: Prevent scatter artifact or false over-subtraction algorithms from completely obscuring a true underlying inferior wall perfusion defect.
  • Identification tip: Look at the raw projections; the subdiaphragmatic structures glow significantly brighter than the myocardium, creating an intense blooming or masking effect.
  • Consultant note: Delayed imaging, or a glass of water or milk/fatty snack before acquisition, speeds hepatobiliary clearance and separates gut activity from the inferior wall.

CViability and metabolism (PET and SPECT)

17.PET Viability Mismatch

  • Analysis: Combined perfusion and metabolic Positron Emission Tomography (PET) study, evaluating tissue survival in a dysfunctional myocardial segment.
  • Morphology: Displays a distinct regional reduction in perfusion (using Nitrogen-13 Ammonia or Rubidium-82) paired with preserved or paradoxically increased metabolic glucose uptake (using Fluorine-18 FDG) in the exact same territory.
  • Clinical goal: Formally diagnose hibernating myocardium to predict a highly significant improvement in left ventricular ejection fraction and long-term survival following targeted mechanical revascularization.
  • Identification tip: Look for the classic "cold" dark area on the perfusion row that turns into a brilliant "hot" glowing area on the FDG metabolic row.
  • Consultant note: Perfusion–metabolism mismatch is the reference pattern for hibernating myocardium: the myocytes are alive but have down-regulated contraction because of chronically reduced flow. Note that the STICH trial did not show that viability testing alone predicts benefit from CABG.

18.PET Viability Match

  • Analysis: Combined blood flow and glucose metabolism PET imaging evaluating an area of permanent regional wall motion abnormality.
  • Morphology: Demonstrates a concordant, matching reduction in both the perfusion tracer intensity and the F-18 FDG metabolic signal within a specific coronary vascular territory.
  • Clinical goal: Confirm a transmural myocardial infarction and non-viable scar tissue to prevent unnecessary, high-risk revascularization procedures.
  • Identification tip: The affected wall remains completely dark and cold across both rows of images, never showing any metabolic activity or perfusion fill-in.
  • Consultant note: Revascularising a matched scar does not improve regional function and adds procedural risk.

19.Thallium-201 Redistribution Scan

  • Analysis: Dual-phase Single-Photon Emission Computed Tomography (SPECT) viability study using a specialized potassium-analog radiotracer.
  • Morphology: Initial post-stress images demonstrate a severe, dark perfusion defect that shows a complete or partial fill-in of tracer intensity on the four-hour or twenty-four-hour delayed rest images.
  • Clinical goal: Establish myocardial cell membrane integrity and tissue viability using a single tracer injection protocol.
  • Identification tip: The cold, dark ischemic zone seen immediately after stress gradually disappears over time on the delayed rest slices due to slow, passive tracer washout and re-equilibration.
  • Consultant note: Thallium-201 uptake requires an intact cell membrane and Na⁺/K⁺-ATPase; redistribution on delayed (or reinjection) images indicates viable myocardium.

20.MUGA Scan

  • Analysis: Gated radionuclide ventriculography utilizing Technetium-99m labeled autologous red blood cells for blood pool imaging.
  • Morphology: Displays a highly reproducible, contrast-independent count-based trace outlining the cyclic contraction and expansion of the left and right ventricular chambers.
  • Clinical goal: Achieve highly precise, operator-independent tracking of the left ventricular ejection fraction, classically used to monitor for cardiotoxicity during doxorubicin or trastuzumab chemotherapy.
  • Identification tip: The raw sequence resembles a low-resolution, beating radioactive pool where global ejection fraction is calculated directly from the absolute change in count density between end-diastole and end-systole.
  • Consultant note: An LVEF fall of 10 percentage points or more to below 50% (or a value below 40%) defines cancer therapy–related cardiac dysfunction (ESC 2022 cardio-oncology); it triggers cardio-oncology review, cardioprotective therapy and usually interruption of the cardiotoxic drug.

DCardiac amyloidosis (Tc-99m PYP/DPD)

21.Tc-99m PYP scan grade 0

  • Analysis: Planar and SPECT imaging using bone-avid radiotracers (Technetium-99m Pyrophosphate or DPD/HMDP) using the Perugini visual grading system.
  • Morphology: Absolutely no radiotracer uptake is visualized within the myocardial tissue; intense, normal physiologic uptake is strictly confined to the bone (ribs and sternum).
  • Clinical goal: Effectively rule out Transthyretin (ATTR) cardiac amyloidosis.
  • Identification tip: The cardiac silhouette is completely invisible or "cold," indistinguishable from the background soft tissue, while the surrounding rib cage lights up brightly.
  • Consultant note: A Grade 0 scan in a patient with a heavily thickened left ventricle strongly points away from ATTR and shifts the diagnostic focus toward AL amyloidosis, hypertensive heart disease, or hypertrophic cardiomyopathy.

22.Tc-99m PYP scan grade 1

  • Analysis: Equivocal bone scintigraphy for cardiac amyloidosis evaluation.
  • Morphology: Mild, faint radiotracer uptake is visible within the cardiac silhouette, but the intensity is visually significantly less than the adjacent rib uptake.
  • Clinical goal: Classify as a negative or non-diagnostic scan for ATTR amyloidosis under current diagnostic guidelines.
  • Identification tip: The heart is barely visible as a faint, ghost-like shadow that is easily outshined by the bright white uptake in the overlying ribs.
  • Consultant note: Grade 1 uptake does not confirm ATTR amyloidosis; it can be seen in early ATTR but also in AL amyloidosis or after a recent myocardial infarction (which also concentrates PYP).

23.Tc-99m PYP scan grade 2

  • Analysis: Positive planar and SPECT bone scintigraphy utilized to diagnose infiltrative cardiomyopathy.
  • Morphology: Moderate, distinct radiotracer accumulation in the myocardium that is visually exactly equal in intensity to the bone uptake of the ribs.
  • Clinical goal: Strongly suggest the diagnosis of Transthyretin (ATTR) Cardiac Amyloidosis.
  • Identification tip: The heart and the ribs glow with the exact same density and brightness; the thickened left ventricular walls can be distinctly outlined against the skeletal background.
  • Consultant note: Grade 2 or 3 uptake with no monoclonal protein on serum free light chains and serum and urine immunofixation is over 98% specific for ATTR cardiac amyloidosis (Gillmore criteria) and allows a non-biopsy diagnosis.

24.Tc-99m PYP scan grade 3

  • Analysis: Definitive, high-intensity positive bone scintigraphy for advanced ATTR cardiac amyloidosis.
  • Morphology: Severe, intense myocardial radiotracer uptake that is visually far greater than the bone uptake, often causing the ribs to appear attenuated or washed out.
  • Clinical goal: Confirm massive, diffuse transthyretin fibril deposition within the myocardial extracellular space.
  • Identification tip: The heart dominates the entire image as a massive, blindingly bright hot spot, while the rib cage looks dark, faint, or completely suppressed due to the severe cardiac tracer sink effect.
  • Consultant note: A heart-to-contralateral (H/CL) lung ratio of 1.5 or more at 1 hour supports a positive Tc-99m PYP scan; SPECT is still needed to confirm myocardial (not blood-pool) uptake.

25.Blood Pool Artifact on PYP Scan

  • Analysis: A critical diagnostic pitfall encountered strictly during planar Tc-99m PYP imaging.
  • Morphology: Persistent, delayed clearance of the radiotracer circulating within the left ventricular cavity mimics true myocardial wall binding on a flat, 2D planar image.
  • Clinical goal: Correctly differentiate true myocardial tissue retention from simple blood pool sluggishness to avoid a disastrous false-positive ATTR diagnosis.
  • Identification tip: On planar images, the heart looks positive, but SPECT imaging definitively shows the tracer is pooled completely inside the central cavity, with the actual myocardial walls remaining totally dark.
  • Consultant note: SPECT (ideally SPECT/CT) is required for every positive planar scan to confirm true myocardial uptake and exclude blood-pool activity, especially with renal failure or a low ejection fraction (ASNC/AHF/EANM consensus).

26.AL Amyloidosis on PYP Scan

  • Analysis: Evaluating the clinical intersection of nuclear imaging and light-chain plasma cell dyscrasias.
  • Morphology: The scan typically reads as Grade 0 or Grade 1, showing negative or minimal radiotracer binding to the myocardium despite profound clinical heart failure.
  • Clinical goal: Recognize that PYP/DPD scans are highly specific for ATTR but completely fail to rule out AL amyloidosis.
  • Identification tip: The heart looks completely normal or only faintly visualized on the scan despite severe echocardiographic or CMR evidence of restrictive cardiomyopathy.
  • Consultant note: If the scan is Grade 0 or 1 but amyloidosis is suspected, exclude AL amyloidosis with serum free light chains and serum and urine immunofixation. AL amyloidosis is a haematological emergency that needs urgent chemotherapy.

ETracers and mechanisms

27.Technetium-99m Sestamibi properties

  • Analysis: Myocardial perfusion radiotracer utilizing a lipophilic cationic complex.
  • Morphology: Passively diffuses across the sarcolemma and binds tightly and irreversibly to the negatively charged inner mitochondrial membrane of viable myocytes.
  • Clinical goal: Provides high-resolution stress and rest perfusion images without the time-sensitive imaging constraints of redistribution.
  • Identification tip: Because sestamibi shows minimal redistribution, a separate rest injection (one-day or two-day protocol) is needed to compare stress and rest images.
  • Consultant note: The higher photon energy and count rate of technetium agents, together with stable myocardial retention, allow good-quality ECG-gated SPECT — giving perfusion, wall motion and LVEF from the same study.

28.Thallium-201 properties

  • Analysis: A monovalent cationic radiotracer that functions physiologically as an exact biological analog of potassium.
  • Morphology: Actively transported into the intracellular space of viable myocardial cells strictly via the ATP-dependent Sodium-Potassium (Na+/K+) ATPase pump.
  • Clinical goal: The classic, historical gold standard for single-injection stress testing and delayed tissue viability assessment via dynamic redistribution.
  • Identification tip: Look for the classic "wash-out" and "fill-in" phenomena on delayed imaging (typically 4 to 24 hours later) as the tracer continually re-equilibrates between the ischemic myocardium and the systemic blood pool.
  • Consultant note: Its active uptake makes thallium well suited to viability assessment (rest–redistribution or stress–redistribution–reinjection), but its long half-life (about 73 hours) and low photon energy give a higher radiation dose and more attenuation than technetium agents.

29.Fluorine-18 FDG properties

  • Analysis: A positron-emitting radiolabeled glucose analog utilized in metabolic Positron Emission Tomography (PET) imaging.
  • Morphology: Enters the myocyte via GLUT transporters and is phosphorylated by hexokinase to FDG-6-phosphate, completely trapping it inside the cell because it cannot proceed further through the glycolytic pathway.
  • Clinical goal: Identify ischaemic but viable (hibernating) myocardium, which shifts from fatty-acid to glucose metabolism.
  • Identification tip: The scan measures pure metabolism; brilliant, intense focal uptake of FDG in a region with an established perfusion defect absolutely confirms viable, hibernating tissue.
  • Consultant note: Fasting myocardium uses mainly free fatty acids, so for viability studies oral glucose loading (with insulin as needed) or a hyperinsulinaemic–euglycaemic clamp is used to drive myocardial glucose uptake.

30.Rubidium-82 properties

  • Analysis: A potassium analog utilized exclusively as a highly active perfusion tracer for cardiac Positron Emission Tomography (PET).
  • Morphology: Extracted into the myocardium via the Na⁺/K⁺-ATPase pump; PET gives higher spatial resolution and routine CT-based attenuation correction compared with standard SPECT.
  • Clinical goal: Fast pharmacological stress–rest perfusion imaging (exercise is impractical because of the short half-life), with absolute myocardial blood flow (MBF) and coronary flow reserve (CFR).
  • Identification tip: The total study time is incredibly short; an entire stress and rest protocol can easily be completed in under 45 minutes due to the tracer's rapid decay.
  • Consultant note: The half-life of about 76 seconds needs a strontium-82/rubidium-82 generator in the nuclear department, but no on-site cyclotron.

FTen tough nuclear cardiology stations

31.Balanced Ischemia on SPECT

  • Analysis: A deceptive phenomenon occurring during myocardial perfusion imaging in the setting of severe, anatomically balanced three-vessel coronary artery disease.
  • Morphology: The relative perfusion images display globally uniform radiotracer uptake without any distinct focal defects, creating a falsely "normal" appearing scan.
  • Clinical goal: Recognize this dangerous false-negative scenario to prevent missing critical Left Main or severe triple-vessel disease.
  • Identification tip: The key clue is the presence of high-risk secondary markers such as Transient Ischemic Dilation (TID), severely blunted heart rate response, or stress-induced ECG changes despite the "normal" perfusion pictures.
  • Consultant note: SPECT measures relative perfusion: if all three territories are equally ischaemic, no relative defect appears. PET with absolute myocardial blood flow is the best way to detect balanced ischaemia.

32.Cardiac Sarcoidosis (FDG PET)

  • Analysis: High-resolution metabolic PET imaging to detect active granulomatous inflammation within the myocardium.
  • Morphology: Shows intense, patchy, and highly focal areas of F-18 FDG radiotracer uptake that completely violate standard epicardial coronary territories.
  • Clinical goal: Establish a definitive diagnosis of active cardiac sarcoidosis to mandate immediate systemic immunosuppression and guide ICD placement.
  • Identification tip: The bright, hot inflammatory spots are scattered irregularly throughout the myocardium, often heavily favoring the basal interventricular septum and the lateral free wall.
  • Consultant note: A high-fat, very-low-carbohydrate diet for 12–24 hours (or more) followed by fasting is needed before the scan to suppress normal myocardial glucose uptake; otherwise the whole heart takes up FDG and masks the disease.

33.Sarcoidosis Mismatch Pattern

  • Analysis: Dual-isotope (Perfusion and Metabolism) PET or SPECT/PET imaging evaluating complex cardiac sarcoidosis.
  • Morphology: A specific myocardial segment displays a clear resting perfusion defect (indicating scar or granulomatous replacement) combined with intense, focal F-18 FDG uptake (indicating active inflammation) in the exact same anatomical location.
  • Clinical goal: Differentiate active, progressive inflammatory lesions from old, burnt-out fibrotic scar tissue to justify initiating or escalating steroid therapy.
  • Identification tip: Look for a dark "cold" spot on the resting perfusion map that lights up as a blindingly bright "hot" spot on the FDG metabolic map.
  • Consultant note: A perfusion defect with matching FDG uptake indicates active inflammation in damaged myocardium and carries a higher risk of ventricular arrhythmias and events.

34.I-123 MIBG Scan for Heart Failure

  • Analysis: Radionuclide imaging utilizing Iodine-123 meta-iodobenzylguanidine to evaluate global cardiac sympathetic nervous system innervation.
  • Morphology: The scan calculates the Heart-to-Mediastinum (H/M) uptake ratio on both early (15 minutes) and late (4 hours) planar images, along with the global washout rate.
  • Clinical goal: Highly advanced risk stratification in chronic heart failure to independently predict the risk of sudden cardiac death and the potential benefit of an ICD.
  • Identification tip: A normal heart is clearly seen (late H/M ratio above about 1.6); a denervated failing heart looks faint against the mediastinal background (late H/M ratio below 1.6, ADMIRE-HF).
  • Consultant note: A late H/M ratio below 1.6 and rapid washout indicate sympathetic denervation and predict heart-failure progression and arrhythmic events.

35.Prosthetic Valve Endocarditis (FDG PET/CT)

  • Analysis: Hybrid metabolic and anatomical imaging targeting suspected infective endocarditis.
  • Morphology: Displays an intense, highly focal "hot spot" of F-18 FDG uptake localized precisely along the anatomical sewing ring of a surgical prosthetic valve or TAVI device.
  • Clinical goal: Provide a major imaging criterion for prosthetic valve endocarditis (ESC 2023 / Duke-ISCVID) when transoesophageal echocardiography is equivocal or limited by prosthesis artifact.
  • Identification tip: The bright metabolic signal strictly outlines the perimeter of the metallic valve on the fused CT slices, proving active perivalvular leukocyte accumulation.
  • Consultant note: A myocardial-suppression diet is needed; within about 3 months of valve surgery, interpret uptake with caution because post-operative inflammation can cause false positives (ESC 2023 endocarditis guidelines).

36.Cardiac Device Infection (Pacemaker/ICD)

  • Analysis: FDG PET/CT hybrid imaging evaluating localized infection in a patient with an implanted cardiac rhythm device and unexplained bacteremia.
  • Morphology: Intense, focal radiotracer uptake tracing the subcutaneous generator pocket or directly following the intravascular trajectory of the pacing leads down into the right heart chambers.
  • Clinical goal: Differentiate active, purulent infection from a sterile pocket hematoma to justify the extremely high-risk procedure of complete transvenous lead extraction.
  • Identification tip: The bright FDG signal physically wraps around the radiopaque metallic generator or forms glowing nodules attached directly to the intracardiac leads on the fused CT.
  • Consultant note: PET/CT is very accurate for pocket infection but less sensitive for lead infection; confirmed CIED infection needs complete system extraction, not antibiotics alone (EHRA 2019).

37.Vasodilator stress — coronary steal

  • Analysis: A paradoxical perfusion response observed during pharmacological stress testing with agents like Adenosine, Regadenoson, or Dipyridamole.
  • Morphology: A patient with a chronic total occlusion (CTO) heavily dependent on collateral flow develops a massive, true perfusion defect only during vasodilator stress.
  • Clinical goal: Understand the microvascular hemodynamics driving true ischemia in a collateralized bed without an increase in myocardial oxygen demand.
  • Identification tip: The normal vessels dilate maximally, dropping their resistance and shunting (stealing) blood flow completely away from the high-resistance collateralized CTO bed, making the CTO territory appear completely dark on the stress images.
  • Consultant note: This confirms that the collateral network, while sufficient at rest, is highly vulnerable and completely inadequate to maintain flow under hyperemic conditions, strongly justifying CTO revascularization.

38.Right-to-Left Shunt on Lung Perfusion Scan

  • Analysis: A macroaggregated albumin (Tc-99m MAA) perfusion scan typically utilized for pulmonary embolism, but applied to structural heart disease.
  • Morphology: Abnormal, intense radiotracer uptake is clearly visualized heavily depositing within the systemic capillary beds, classically lighting up the brain and the kidneys.
  • Clinical goal: Definitively prove and visually quantify the presence of a macroscopic right-to-left intracardiac or intrapulmonary shunt (e.g., Eisenmenger syndrome or a massive ASD/PFO).
  • Identification tip: MAA particles (10–90 micrometres) are normally trapped in the pulmonary capillaries; uptake in the brain and kidneys proves a right-to-left shunt.
  • Consultant note: Reduce the number of injected MAA particles in known right-to-left shunt or severe pulmonary hypertension to limit systemic microembolisation.

39.Absolute Myocardial Blood Flow (PET Quantification)

  • Analysis: Advanced quantitative analysis derived exclusively from dynamic cardiac PET imaging (using Rubidium-82 or N-13 Ammonia).
  • Morphology: A digital printout or polar map calculating the precise global and regional Coronary Flow Reserve (CFR), which is the ratio of hyperemic blood flow to resting blood flow in milliliters per minute per gram of tissue.
  • Clinical goal: Diagnose coronary microvascular dysfunction (INOCA) or confirm balanced multivessel disease when relative perfusion images look normal.
  • Identification tip: The relative perfusion maps look completely uniform, but the absolute CFR numbers printed on the report are globally reduced to less than 2.0 across all three vascular territories.
  • Consultant note: Normal CFR on PET is above about 2.0–2.5; a globally reduced CFR is a strong independent predictor of cardiovascular death and calls for intensive medical therapy even if the epicardial arteries look smooth.

40.Myocardial Infarction "Hot Spot" Imaging (Tc-99m PYP)

  • Analysis: A historical diagnostic technique utilizing Technetium-99m Pyrophosphate to image acute myocardial necrosis.
  • Morphology: A highly localized, bright "hot spot" of tracer uptake appearing strictly within the anatomical borders of a recently infarcted myocardial segment.
  • Clinical goal: Confirm a recent acute myocardial infarction in scenarios where ECGs (like LBBB) and cardiac biomarkers are completely equivocal or time-delayed.
  • Identification tip: Imaging is best done 24–72 hours after the event; the tracer binds to calcium deposits (calcium-phosphate complexes) in irreversibly injured myocytes.
  • Consultant note: While largely replaced by high-sensitivity troponins and CMR, this remains a highly tested physiological concept on exams to prove your understanding of necrotic calcium kinetics and tracer mechanisms.

Classes and cut-offs follow the ESC 2020–2024 and ACC/AHA guidelines current in October 2026; always apply your own institution's protocols.

meritmedscript.comDr. Sidhartha Mullapudi